Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurogene (NGNE – Research Report) today and set a price target of $46.00. The ...
Stifel lowered the firm’s price target on Tesla (TSLA) to $474 from $492 and keeps a Buy rating on the shares. The firm cites the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback